Showing results (31-40 of 267) with videos related to
Sort By:
Pageof 27
Pediatric Blood & Cancer|February 23, 2008
Resolution of chronic hypoxemia in pediatric sickle cell patients after treatment with hydroxyureaSharon A Singh, Anastassios C Koumbourlis, Banu AygunAmerican Journal of Hematology|February 9, 2024
Reducing transfusion utilization for children with sickle cell anemia in sub-Saharan Africa with hydroxyurea: Analysis from the phase I/II REACH trialAlexandra Power-Hays, George A Tomlinson, Leon Tshilolo, et al.American Journal of Hematology|November 25, 2003
Malignancy in patients with sickle cell diseaseWilliam H Schultz, Russell E WareCurrent Opinion in Hematology|March 25, 2020
Effective use of hydroxyurea for sickle cell anemia in low-resource countriesAlexandra Power-Hays, Russell E WarePediatric Clinics of North America|April 3, 2008
Hydroxyurea for children with sickle cell diseaseMatthew M Heeney, Russell E WarePediatric Blood & Cancer|December 11, 2024
The Voxelotor Effect: Decreased Affinity for New Drugs for Sickle Cell Disease?Charles T Quinn, Russell E WareHaematologica|January 9, 2025
The modern use of hydroxyurea for children with sickle cell anemiaCharles T Quinn, Russell E WareBritish Journal of Haematology|October 25, 2023
Screening for haemoglobin disorders: One size may not fit allLisa M Shook, Russell E WareExpert Opinion on Drug Safety|September 15, 2015
Hydroxyurea therapy for sickle cell anemiaPatrick T McGann, Russell E WarePediatric Blood & Cancer|February 9, 2018
Children with sickle cell disease migrating to the United States from sub-Saharan AfricaCourtney D Thornburg, Russell E WarePageof 27